3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
69
Carcinoma, Intraductal, Noninfiltrating
9
Breast Carcinoma In Situ
6
Breast Neoplasms, Male
5
Neoplasms
3
Neoplasm Metastasis
3
Urinary Bladder Neoplasms
2
Inflammatory Breast Neoplasms
2
Sleep Wake Disorders
1
Risk Reduction Behavior
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Obesity
1
Newly Diagnosed Hormone Positive Clinical Stage 1 or 2 Breast Cancer
1
Mastodynia
1
Glioma
1
Fibrocystic Breast Disease
1
Fibroadenoma
1
Fatigue
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Disease Progression
1
Desmoid Tumors
1
Cystic Fibrosis
1
Cystadenocarcinoma, Serous
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Lobular
1
Bulbo-Spinal Atrophy, X-Linked
1
Breast Cancer Metastatic
1
Interventions
Sorafenib
23
Bevacizumab
11
Radiosurgery
6
Capecitabine
6
Radiofrequency Ablation
5
Oxaliplatin
5
Fluorouracil
5
Doxorubicin
5
pembrolizumab
4
Sunitinib
4
Erlotinib Hydrochloride
4
Cisplatin
4
Ramucirumab
3
Radiotherapy
3
Nivolumab
3
Leucovorin
3
Carboplatin
3
tremelimumab
2
spartalizumab
2
perflutren
2
derazantinib
2
carotuximab
2
Mitomycin
2
Magnetic Resonance Spectroscopy
2
Magnetic Resonance Imaging
2
Ipilimumab
2
Immunohistochemistry
2
Gemcitabine
2
Folfox protocol
2
Fluorodeoxyglucose F18
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Liver Neoplasms
×
Tamoxifen
×
Clear all
No trials found.